17.28
0.11 (0.64%)
| Previous Close | 17.17 |
| Open | 17.13 |
| Volume | 1,390,614 |
| Avg. Volume (3M) | 2,257,973 |
| Market Cap | 4,909,143,040 |
| Price / Earnings (TTM) | 86.40 |
| Price / Earnings (Forward) | 19.53 |
| Price / Sales | 4.32 |
| Price / Book | 8.96 |
| 52 Weeks Range |
| Profit Margin | 2.24% |
| Operating Margin (TTM) | 27.86% |
| Diluted EPS (TTM) | 0.090 |
| Quarterly Revenue Growth (YOY) | 2.60% |
| Quarterly Earnings Growth (YOY) | -68.10% |
| Total Debt/Equity (MRQ) | 566.88% |
| Current Ratio (MRQ) | 2.46 |
| Operating Cash Flow (TTM) | 269.99 M |
| Levered Free Cash Flow (TTM) | 194.97 M |
| Return on Assets (TTM) | 7.01% |
| Return on Equity (TTM) | 5.88% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Bullish | Bullish |
| Diagnostics & Research (Global) | Bullish | Bullish | |
| Stock | Sotera Health Company | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.88 |
|
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Core |
| % Held by Insiders | 2.51% |
| % Held by Institutions | 95.98% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Warburg Pincus Llc | 30 Sep 2025 | 61,822,952 |
| Mig Capital, Llc | 30 Sep 2025 | 4,226,810 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 24.00 (RBC Capital, 38.89%) | Buy |
| 24.00 (Piper Sandler, 38.89%) | Buy | |
| Median | 24.00 (38.89%) | |
| Low | 23.00 (Citigroup, 33.10%) | Buy |
| Average | 23.67 (36.98%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 18.62 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 24 Feb 2026 | 23.00 (33.10%) | Buy | 17.45 |
| Piper Sandler | 09 Jan 2026 | 24.00 (38.89%) | Buy | 19.20 |
| RBC Capital | 09 Jan 2026 | 24.00 (38.89%) | Buy | 19.20 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Feb 2026 | Announcement | Sotera Health Appoints Richard Kyle to the Board of Directors |
| 12 Jan 2026 | Announcement | Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference |
| 07 Jan 2026 | Announcement | Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |